About this application
AGAR conducts resistance surveys for Staphylococcus aureus, some Enterobacteriaceae (E. coli, Enterobacter spp., and Klebsiella spp.), Haemophilus influenzae, Streptococcus pneumoniae and Enterococcus spp. In addition to antibiotic susceptibility testing, S. aureus is typed using a variety of molecular techniques.
By using standardised methodology AGAR has been able to collect trend data. AGAR is making this information available to the broader community with the aim of assisting appropriate antibiotic selection and to provide data for public health intervention to contain antibiotic resistance in Australia.
About AGAR
The Australian Group on Antimicrobial Resistance (AGAR) is a unique collaboration of clinicians and scientists from major microbiology laboratories around Australia. Participating laboratories test and gather information on antibiotic resistance in bacteria of clinical importance. Starting in 1985 with 13 teaching hospitals, AGAR now has 30 institutions including 4 private laboratories. The composition of AGAR enables the monitoring of antibiotic resistance in major teaching hospitals, private hospitals and in the community for each Australian State and Territory
The development of this App has been made possible by a generous unrestricted educational grant from Pfizer Australia to the Australian Society for Antimicrobials (the corporate partner of AGAR)